Hemolytic Uremic Syndrome, Atypical 1 (AHUS1)

Alias:

Atypical Hemolytic-Uremic Syndrome

Atypical Hemolytic Uremic Syndrome

Hemolytic Uremic Syndrome, Atypical, Susceptibility to, 1

Ahus

Hemolytic Uremic Syndrome, Atypical, Susceptibility to

Hemolytic-Uremic Syndrome

Atypical Hus

Ahus1

Hemolytic Uremic Syndrome Associated with Shiga Toxin-Producing Escherichia Coli

Atypical Hemolytic Uremic Syndrome with Anti-Factor H Antibodies

Atypical Hemolytic-Uremic Syndrome with Anti-Factor H Antibodies

Atypical Hemolytic Uremic Syndrome with H Factor Anomaly

Ahus with Neutralizing Autoantibodies Against Factor H

Shiga Toxin-Associated Hemolytic Uremic Syndrome

Hemolytic-Uremic Syndrome, Atypical, Type 1

Atypical Hus with Anti-Factor H Antibodies

Hemolytic-Uremic Syndrome Without Diarrhea

Hemolytic Uremic Syndrome with Diarrhea

Hemolytic Uremic Syndrome Atypical 1

Hemolytic Uremic Syndrome, Atypical

Non-Shiga-Like Toxin-Associated Hus

Ahus with Anti-Factor H Antibodies

Hemolytic Uremic Syndrome, Typical

Typical Hemolytic Uremic Syndrome

Shiga-Like Toxin-Associated Hus

Ahus, Susceptibility to, 1

Nonenteropathic Hus

Non-Stx-Hus

Typical Hus

Ehec-Hus

Stec-Hus

Stx-Hus

Ahus 1

D+ Hus

D Hus

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Hemolytic Uremic Syndrome, Atypical 1, also known as atypical hemolytic-uremic syndrome, is related to genetic atypical hemolytic-uremic syndrome and atypical hemolytic uremic syndrome with complement gene abnormality. An important gene associated with Hemolytic Uremic Syndrome, Atypical 1 is CFH (Complement Factor H), and among its related pathways/superpathways are Innate Immune System and Diseases of hemostasis. The drugs Eculizumab and Complement System Proteins have been mentioned in the context of this disorder. Affiliated tissues include kidney and skin, and related phenotypes are proteinuria and thrombocytopenia

Related ID：

MALACARDS：HML033

OMIM：235400

MESH：D006463